183 related articles for article (PubMed ID: 7592749)
21. Catalytic strategies of self-cleaving ribozymes.
Cochrane JC; Strobel SA
Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
[TBL] [Abstract][Full Text] [Related]
22. Activity of hammerhead ribozymes containing non-nucleotidic linkers.
Thomson JB; Tuschl T; Eckstein F
Nucleic Acids Res; 1993 Dec; 21(24):5600-3. PubMed ID: 7506829
[TBL] [Abstract][Full Text] [Related]
23. The structure, function and application of the hammerhead ribozyme.
Birikh KR; Heaton PA; Eckstein F
Eur J Biochem; 1997 Apr; 245(1):1-16. PubMed ID: 9128718
[TBL] [Abstract][Full Text] [Related]
24. Structural Simplicity and Mechanistic Complexity in the Hammerhead Ribozyme.
O'Rourke SM; Scott WG
Prog Mol Biol Transl Sci; 2018; 159():177-202. PubMed ID: 30340787
[TBL] [Abstract][Full Text] [Related]
25. The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes.
Zoumadakis M; Neubert WJ; Tabler M
Nucleic Acids Res; 1994 Dec; 22(24):5271-8. PubMed ID: 7816616
[TBL] [Abstract][Full Text] [Related]
26. Hammerhead ribozyme engineering.
Usman N; Beigelman L; McSwiggen JA
Curr Opin Struct Biol; 1996 Aug; 6(4):527-33. PubMed ID: 8794164
[TBL] [Abstract][Full Text] [Related]
27. Chemically modified hammerhead ribozymes with improved catalytic rates.
Burgin AB; Gonzalez C; Matulic-Adamic J; Karpeisky AM; Usman N; McSwiggen JA; Beigelman L
Biochemistry; 1996 Nov; 35(45):14090-7. PubMed ID: 8916894
[TBL] [Abstract][Full Text] [Related]
28. In vitro selection of a novel nuclease-resistant RNA phosphodiesterase.
Beaudry A; DeFoe J; Zinnen S; Burgin A; Beigelman L
Chem Biol; 2000 May; 7(5):323-34. PubMed ID: 10801472
[TBL] [Abstract][Full Text] [Related]
29. Replacement of the phosphodiester bond between U4 and G5 in the U-turn of a chemically modified hammerhead ribozyme by an amide bond.
Dunkel M; Reither V
Nucleosides Nucleotides Nucleic Acids; 2000 Apr; 19(4):749-56. PubMed ID: 10960033
[TBL] [Abstract][Full Text] [Related]
30. A core folding model for catalysis by the hammerhead ribozyme accounts for its extraordinary sensitivity to abasic mutations.
Peracchi A; Karpeisky A; Maloney L; Beigelman L; Herschlag D
Biochemistry; 1998 Oct; 37(42):14765-75. PubMed ID: 9778351
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections.
Desjardins JP; Sproat BS; Beijer B; Blaschke M; Dunkel M; Gerdes W; Ludwig J; Reither V; Rupp T; Iversen PL
J Pharmacol Exp Ther; 1996 Sep; 278(3):1419-27. PubMed ID: 8819529
[TBL] [Abstract][Full Text] [Related]
32. Zinc-dependent cleavage in the catalytic core of the hammerhead ribozyme: evidence for a pH-dependent conformational change.
Borda EJ; Markley JC; Sigurdsson ST
Nucleic Acids Res; 2003 May; 31(10):2595-600. PubMed ID: 12736309
[TBL] [Abstract][Full Text] [Related]
33. Cellular delivery of hammerhead ribozymes conjugated to a transferrin receptor antibody.
Hudson AJ; Normand N; Ackroyd J; Akhtar S
Int J Pharm; 1999 May; 182(1):49-58. PubMed ID: 10332074
[TBL] [Abstract][Full Text] [Related]
34. Improvement of hammerhead ribozymes cleaving mdr-1 mRNA.
Palfner K; Kneba M; Hiddemann W; Bertram J
Biol Chem Hoppe Seyler; 1995 May; 376(5):289-95. PubMed ID: 7544982
[TBL] [Abstract][Full Text] [Related]
35. Binary hammerhead ribozymes with high cleavage activity.
Kuznetsova M; Novopashina D; Repkova M; Venyaminova A; Vlassov V
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):1037-42. PubMed ID: 15560099
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase.
Sioud M; Jespersen L
J Mol Biol; 1996 Apr; 257(4):775-89. PubMed ID: 8636981
[TBL] [Abstract][Full Text] [Related]
37. Nuclease resistant hammerhead motif: from '5-ribo' to '3-ribo' model.
Matulic-Adamic J; Daniher AT; Gonzalez C; Beigelman L
Bioorg Med Chem Lett; 1999 Jan; 9(2):157-60. PubMed ID: 10021919
[TBL] [Abstract][Full Text] [Related]
38. NMR spectroscopic characterization of a model RNA duplex reflecting the core sequence of hammerhead ribozymes.
Hattori Y; Yamanaka D; Morioka S; Yamaguchi T; Tomonari H; Kojima C; Tanaka Y
Nucleosides Nucleotides Nucleic Acids; 2018; 37(7):383-396. PubMed ID: 29953330
[TBL] [Abstract][Full Text] [Related]
39. Study of a hammerhead ribozyme containing 2'-modified adenosine residues.
Olsen DB; Benseler F; Aurup H; Pieken WA; Eckstein F
Biochemistry; 1991 Oct; 30(40):9735-41. PubMed ID: 1911762
[TBL] [Abstract][Full Text] [Related]
40. Chemically modified RNA: approaches and applications.
Heidenreich O; Pieken W; Eckstein F
FASEB J; 1993 Jan; 7(1):90-6. PubMed ID: 7678566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
